CAMBRIDGE, Mass. and SAN FRANCISCO, Calif., – April 07, 2026 – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate Kytopen’s global commercial expansion and drive further adoption of its Flowfect® technology platform across the U.S. and Europe. As part of the investment, Telegraph Hill Partners will join Kytopen’s Board of Directors.
Kytopen’s continuous flow transfection technology combines mechanical, electrical, and chemical forces to rapidly engineer hundreds of billions of healthy, high-quality cells in minutes. Designed for flexibility and scalability, the platform integrates seamlessly into closed GMP workflows, and the gentleness of the technology supports the full spectrum of cell therapy modalities. Its Flowfect Tx® GMP and Flowfect Discover™ 96-well systems enable a streamlined path from feasibility and optimization to clinical and commercial-scale manufacturing. Through its strategic partnerships, Kytopen will advance a new generation of cell therapies designed to revolutionize treatment across multiple disease areas.
“Kytopen’s Flowfect technology has demonstrated the ability to genetically modify a broad range of therapeutic cell types in higher quantities, with better cell health and with lower cost than existing methods” said Matthew Mackowski, Chairman, Managing Director at Telegraph Hill Partners. “Adoption of technologies like Kytopen’s will be essential to achieving broader community access to potentially curative cell therapies by lowering costs, shortening turn-around-time, and reducing variability.”
“We welcome Telegraph Hill Partners to our investor base at this pivotal stage,” said Michael Chiu, CEO of Kytopen. “With strong and growing customer demand, this investment enables us to scale globally while continuing to invest in the infrastructure needed to support our partners in delivering cost-effective, advanced cell therapies worldwide.”